Demise of Polymerase Chain Reaction/Electrospray Ionization-Mass Spectrometry as an Infectious Diseases Diagnostic Tool

Clicks: 260
ID: 117153
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #36 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
PCR/electrospray ionization-mass spectrometry had been under development for over a decade. It had become commercially available in Europe in 2014 and was under
Reference Key
volkan2018clinicaldemise Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Özenci, Volkan;Patel, Robin;Ullberg, Måns;Strålin, Kristoffer;
Journal clinical infectious diseases
Year 2018
DOI
DOI not found
URL
https://academic.oup.com/cid/article/66/3/452/4085939
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't United States united states food and drug administration polymerase chain reaction* bacteremia / diagnosis kristoffer strålin communicable diseases / diagnosis* robin patel spectrometry sepsis / diagnosis mass pmid:29020209 doi:10.1093/cid/cix743 volkan Özenci molecular diagnostic techniques / standards electrospray ionization*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.